A Finger-Sweat Ring Reads Glucose Without Needles. Surviving Clinical Trials Is the Hard Part.

A UC San Diego team has built the first smart ring that can read glucose, ketones, and other biochemicals from finger sweat. The chemistry problem that has stymied every previous attempt at noninvasive glucose monitoring now has a working answer. The clinical problem, whether a sweat-reading ring can replace a blood test in real patients, is still open.

The device, called CHARM (Continuous Health Analyzing Ring Module), is a research prototype reported in Nature Communications, not a product. It belongs to a different category than the Oura Ring 5 or Samsung Galaxy Ring sitting on retail shelves. Those rings read biophysical signals: heart rate, skin temperature, motion, sleep stages. They see light pass through tissue. They cannot see glucose.

CHARM reads chemistry. It does so by exploiting a piece of physiology the wrist-based wearables industry has largely ignored: the fingers sweat constantly, even at rest. "Other wearable sweat sensors rely on exercise to produce sweat, but nobody wants to work out to take a measurement," according to the study's authors.

The ring solves the exercise problem with an osmotic hydrogel, a polymer disk that pulls water out of the skin on its own by exploiting a salt gradient. The sweat wicks into a chamber lined with electrochemical sensors, which oxidize each target molecule and read the resulting current. The array tracks six biomarkers: glucose, ketone, ascorbic acid (vitamin C), uric acid, lactate, and alcohol. Four are measured at a time, in any combination the wearer chooses.

In trials with participants with and without Type 1 diabetes, CHARM's glucose readings closely matched a continuous glucose monitor, and its ketone readings matched a traditional blood meter. The lab says the ring supports roughly 12 hours of continuous monitoring on a charge and holds its personalized calibration for about two months.

Those numbers are also the first sign of how far the device has to go. The current prototype has no convenient recharging method, according to the Gizmodo writeup, and the Nature paper itself notes that sustained multi-day monitoring will require further advances in hydrogel engineering. A 12-hour ring with no recharge dock is a research tool, not a sleep tracker.

The lab, led by Joseph Wang, a professor in the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering at the UC San Diego Jacobs School of Engineering, has spent years on sweat-sensing chemistry. The mechanism now works. The four gaps that separate this device from a pharmacy shelf are: comprehensive clinical validation across the full glycemic spectrum, a battery that lasts long enough to be useful, a way to recharge the ring without taking it off, and a hydrogel that can survive days of wear without drying out, leaking, or losing calibration.

Continuous glucose and ketone monitoring matters because it can help determine optimal insulin dosage, especially for people with Type 1 diabetes, and because a needle-free alternative has been the field's white whale since the first continuous glucose monitor (CGM) hit the market. The authors flag that CHARM has not yet been validated comprehensively in different clinical settings or across the full glycemic range, the lows and highs where insulin decisions get dangerous.

The chemistry has caught up to the engineering question. The engineering question has not yet caught up to the clinical question. Watch the next round of papers from the same team, or from competitors chasing the same problem from other angles, to see whether the validation gap, the battery gap, or the hydrogel gap closes first.